Investors are discouraged after it releases the latest data for its top drug.
Compare PANC.DL Stock to Peers
|Symbol||Last Price||Market Cap||% Δ 1 Yr||% Δ 5 Yr|
Panacos Pharmaceuticals Inc.
News & Analysis: Panacos Pharmaceuticals Inc.
Are they cheap for a reason, or are they overlooked investment opportunities?
Panacos announces new data for its lead drug.
The company announces another slight delay with its lead drug.
An interview with Panacos Pharmaceuticals CEO Alan Dunton.
Panacos gives guidance for the remainder of the year.
Who's fallen hardest? Who can bounce highest?
Panacos releases more clinical trial results for an exciting drug.
Panacos, Acadia and Encysive are ready to go.
Panacos details the plan for clinical testing of its lead compound.